With positive revenue and earnings news we can start building a base and increase the daily number of shares traded. Far too thin with a correspondingly huge beta. I've been here since .19 and continue to hold waiting for the Motorola contract to start reaping long-term benefits.
Now 48754. Same market maker. So someone looking to sell a lot of stock. Time for them to move on and take a profit and go on that long sought after vacation in Europe.
Yes. And they need more to keep paying the bills, continue research and conduct their in vitro, animal and clinical trials.
You may want to learn about startups, especially a fledgling pharmaceutical company. Take a look at the annual report that Pieris just released so that you can educate yourself. Since you don't understand the stock or the company, perhaps you may want to wait until (or if) they have a viable product. This is the clinical trials stage. It costs a lot of money to test a drug, hopefully get FDA approval and then bring it to market. The company will continue to spend millions of dollars a year with zero revenue until and if they have something to sell. Cash burn is what happens when you are a drug company in its infancy. That is what they all do at this stage. They make it or they don't. A shareholder loses their entire investment or makes a lot of money. That is the risk one takes. One goes to sleep and wakes up either when the company declares bankruptcy or gets FDA approval and thereafter has a drug that produces significant revenues. Once they have a profit they can get out of debt. Then they have earnings. Then the stock goes up and shareholders make money. It is a several year wait. It takes patience and an understanding of the process. There will be more public offerings. There will be more public offerings. They will need to continually raise cash. This is a speculative investment. High risk and high potential reward. If you want something safer, buy Apple.
Not everyone. LG sold over 100,000 OLED TVs first quarter. I have a 2016 LG OLED 55e6p. It is extraordinary. Getting an LED TV at this point in time is a waste of money in comparison. I would rather have a 55" OLED than a 65" LED, even if they were both the same price.
Sentiment: Strong Buy
QLED is still inferior to OLED, as you yourself said. And if QLED is, as you assert, getting better, then OLED (the company) is not sitting on its hands when it comes to improving their product. See for your self, as I did. I went to Best Buy and assuming both TVs are set up correctly, there was Samsung's highest end QLED TV sitting next to a 2015 (not even 2016, which I own) LG OLED. There was no comparison. The OLED TV was far superior in picture quality. To buy a QLED TV which is not that much less than the least expensive OLED 2016 LG models, is a waste of money.
No. Regardless, QLED is an inferior product. http://www.extremetech.com/computing/214661-quantum-dots-oled-go-head-to-head-in-65-inch-displaymate-shootout
Looks like someone sold a lot of shares at 11:30am that dropped the stock and set up the day's subsequent trades at lower levels than we've been experiencing. Someone needed some cash. We're still flying far under the radar.
Article on Yahoo news. This is excellent news with extraordinarily high potential.
HemaCare Corporation, (HEMA) a leader in cell and tissue collection, processing, and cell therapy solutions, has expanded its global capabilities through a strategic distribution agreement in China with Shanghai-based MT-Biological Science and Technology Co. Ltd. This partnership ensures researchers in China can access HemaCare’s human healthy and disease state cryopreserved hematopoietic cell products for their basic scientific and cell therapy research and development needs in a timely manner and with local region support.
Sentiment: Strong Buy
Got filled today at .72. "Only" 2400 shares and got impatient. Figured lots of shares bid just behind me at .70-.71 so better take the .72.
I highly suggest folks with interest in Zoom to give it a listen. The link is within the "Investor" section of their website. If things go according to plan this will be a very productive year that will form the foundation for a solid future.
Having worked for the FDA for 10 years, this makes perfect sense. Rather than a case by case basis,a regulation to cover all current and future companies to stop and prevent restrictive practices (hopefully).
It is possible that I read it in Eyeball's newsletter, but I am not positive. Perhaps he can weigh in on this. If he did have it in his newsletter then the question becomes where did he get the information. Maybe another question for Peter if you have yet to call. I don't like to contact him too often.
I can't find it but I could swear I remember reading this. Maybe someone else remembers this, as well.
Sentiment: Strong Buy